Therapeutic sequences in patients with grade 1−2 neuroendocrine tumors (NET): an observational multicenter study from the ELIOS group

A. Faggiano,Silvana Di Maio,Carmela Mocerino,Margaret Ottaviano,Chiara De Divitiis,Valentina Guarnotta,Pasquale Dolce,Roberta Modica,Ivana Puliafito,Lucia Tozzi,Antonella Di Sarno,S Leo,Ferdinando Riccardi,Giovannella Palmieri,Salvatore Tafuto,A. Bianco,Giuseppe Badalamenti,Annamaria Colao

Therapeutic sequences in patients with grade 1−2 neuroendocrine tumors (NET): an observational multicenter study from the ELIOS group

2019

A. Faggiano
Silvana Di Maio
Carmela Mocerino
Margaret Ottaviano
Chiara De Divitiis
Valentina Guarnotta
Pasquale Dolce
Roberta Modica
Ivana Puliafito
Lucia Tozzi
Antonella Di Sarno
S Leo
Ferdinando Riccardi
Giovannella Palmieri
Salvatore Tafuto
A. Bianco
Giuseppe Badalamenti
Annamaria Colao

Purpose Many different treatments are suggested by guidelines to treat grade 1−2 (G1−G2) neuroendocrine tumors (NET). However, a precise therapeutic algorithm has not yet been established. This study aims at identifying and comparing the main therapeutic sequences in G1−G2 NET.

Keywords:

Biology
Endocrinology
Internal medicine
Oncology
Observational study
Targeted therapy
Neuroendocrine tumors
Diabetes mellitus
therapeutic algorithm
multicenter study
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations